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unctional development of mammary epithelium during
 
pregnancy depends on prolactin signaling. However,
the underlying molecular and cellular events are not
fully understood. We examined the speciﬁc contributions
of the prolactin receptor (PrlR) and the signal transducers
and activators of transcription 5a and 5b (referred to as
 
Stat5) in the formation and differentiation of mammary
alveolar epithelium. PrlR- and Stat5-null mammary epithelia
 
were transplanted into wild-type hosts, and pregnancy-
 
mediated development was investigated at a histological and
molecular level. Stat5-null mammary epithelium developed
ducts but failed to form alveoli, and no milk protein gene
expression was observed. In contrast, PrlR-null epithelium
F
 
formed alveoli-like structures with small open lumina.
Electron microscopy revealed undifferentiated features of
organelles and a perturbation of cell–cell contacts in PrlR-
and Stat5-null epithelia. Expression of NKCC1, an Na-K-Cl
cotransporter characteristic for ductal epithelia, and ZO-1,
a protein associated with tight junction, were maintained
in the alveoli-like structures of PrlR- and Stat5-null epithelia.
In contrast, the Na-Pi cotransporter Npt2b, and the gap
junction component connexin 32, usually expressed in
secretory epithelia, were undetectable in PrlR- and Stat5-
null mice. These data demonstrate that signaling via the PrlR
and Stat5 is critical for the proliferation and differentiation of
mammary alveoli during pregnancy.
 
Introduction
 
Cytokines, such as prolactin (Prl),* growth hormone (GH),
interleukin (IL)-2, and erythropoietin (Epo) elicit a wide
range of cell-specific responses including cell proliferation,
survival, differentiation, and death. Upon binding of these
cytokines to their respective receptors, the receptor-associ-
ated kinase Jak2 phosphorylates the latent transcription fac-
tors signal transducer and activator of transcription (Stat)5a
and Stat5b at tyrosines 694/699, respectively. Upon activa-
tion, Stat5a and Stat5b form homo- and heterodimers that
translocate to the nucleus and induce cell-specific genetic
programs. In erythroid cells, Epo-induced Stat5 activation
may lead to the transcriptional activation of the 
 
bcl
 
-
 
x
 
 gene
and thus promote cell survival (Socolovsky et al., 1999), and
in T cells, IL-2–mediated cell proliferation is severely im-
paired in the absence of Stat5 (Teglund et al., 1998; Moriggl
et al., 1999).
Development of the mammary gland occurs predomi-
nantly in the postnatal animal and is controlled by steroid
and peptide hormones (Hennighausen and Robinson, 1998,
2001). Proliferation and differentiation of mammary alveo-
lar epithelia occurs during pregnancy through prolactin and
its receptor (PrlR) (Ormandy et al., 1997b). Stat5a-null
mice fail to develop functional mammary tissue during preg-
nancy, mainly as a result of impaired functional differentia-
tion and not due to the lack of lobulo-alveolar units (Liu et
al., 1997). After multiple pregnancies, functional mammary
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development was attained in Stat5a-null mice (Liu et al.,
1998). This phenotype was accompanied by increased levels
of active Stat5b, suggesting that Stat5b can partially com-
pensate for the absence of Stat5a. However, Stat5b itself is
not required for lactation (Teglund et al., 1998). Because
mice carrying inactivated Stat5a and 5b (referred to as Stat5
throughout the text) genes are infertile, the combined func-
tion of both Stat5a and 5b during pregnancy had not been
investigated.
Components of regulatory pathways are in many cases not
exclusive, and may participate in several signaling cascades.
In mammary epithelia, Stat5 is activated through the PrlR,
but also by GH and the epidermal growth factor receptors
(Gallego et al., 2001), and possibly the 
 
Src
 
 pathway (Kazan-
sky et al., 1999). In addition, the PrlR not only activates
Stat5 via Jak2, but also stimulates the mitogen-activated pro-
tein kinase and phosphoinositide 3-kinase (PI3K) pathways
(Bole-Feysot et al., 1998; Kim and Cochran, 2001). If mam-
mary alveolar epithelial development depends on a pathway
that includes the PrlR and Stat5, a similar phenotype should
be expected in the respective gene deletion mice. However, if
Prl-independent Stat5 activation controls some steps of de-
velopment, a different phenotype would be expected in the
absence of the two components (i.e., PrlR and Stat5).
We have now investigated the relative contributions of
Stat5 and the PrlR in pregnancy-induced mammary epithe-
lial development. Although gross morphological analyses
have linked the PrlR (Ormandy et al., 1997a) and Stat5a
(Liu et al., 1997) to cell proliferation and differentiation, the
molecular and cellular mechanisms of prolactin and Stat5
signaling are not understood. Specifically, the combined roles
of Stat5a and 5b during pregnancy-induced mammopoiesis
are not known. It remains unclear whether the Prl pathway is
actually required for the acquisition of a particular cell fate,
or whether it controls the differentiation of an already speci-
fied cell type. We have used molecular markers that can dis-
tinguish between different mammary epithelial cell types in
the developing mammary gland to investigate the role of
PrlR and Stat5 in the development of alveolar epithelium.
 
Results
 
Development of mammary tissue in PrlR- and
Stat5-null mice
 
Although the PrlR is required for development of mammary
epithelium during pregnancy (Ormandy et al., 1997b), the
contribution of Stat5 in this process is not known. Stat5 is
downstream of the PrlR, and it can be hypothesized that the
loss of either signaling component might lead to a compara-
ble phenotype. To investigate this, we compared the preg-
nancy-induced development of PrlR- and Stat5-null epi-
thelia. Because Stat5- and PrlR-null mice are infertile,
Figure 1. Pregnancy-mediated 
mammary gland development depends 
on the PrlR and Stat5. (A) Whole mount 
analyses of wild-type, PrlR-, and Stat5-
null mammary epithelia at parturition. 
The lower panel represents a higher 
magnification. Wild-type epithelium 
filled the fat pad and developed 
lobuloalveolar structures (*). PrlR- and 
Stat5-null mammary epithelia were 
severely underdeveloped. PrlR-null 
epithelium exhibited wide ducts (black 
arrow), short branches, and few alveoli-
like structures. Stat5-null epithelium 
displayed normal branches with small 
decorations (black arrowhead). (B) 
Histological sections of the whole 
mounts shown in A. The lower panel 
represents a 6  higher magnification. 
Wild-type epithelium was fully 
expanded, filled the fat pad and alveolar 
lumina contained milk (*). However, all 
null epithelia were sparse, and the 
alveoli-like structures (black arrowhead) 
did not contain milk. The epithelial cells 
are cuboidal in shape (white arrow). 
Note the presence of open lumina in the 
alveoli-like structures in PrlR-, but not 
Stat5-null epithelium. (C) Whole mount 
analyses of wild-type and PrlR- and 
Stat5-null virgin mammary epithelia 8 
wk after transplantation. All transplanted 
epithelia completely filled the fat pad. 
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mammary epithelia from mature virgins was transplanted
into the cleared fat pad of recipients to expose these epithelia
to pregnancy hormones. Whole mount analyses demon-
strated that ductal development during puberty was not af-
fected in PrlR- and Stat5-null mice (Fig. 1 C). In contrast,
pregnancy-mediated alveolar development was severely im-
paired (Fig. 1 A). Whereas wild-type ducts were decorated
with expanded alveoli, the epithelium was greatly reduced in
Stat5-null transplants and did not have the appearance of
true lobulo-alveolar units. Histological sections demon-
strated that the majority of Stat5-null alveoli-like structures
did not have lumina (Fig. 1 B, right panel). Furthermore, in-
dividual Stat5-null epithelial cells exhibited abnormal co-
lumnar shapes and the epithelial architecture appeared disor-
ganized (Fig. 1 B, right panel, white arrow). On the other
hand, small open lumina were evident in the more organized
alveoli-like structures in the PrlR-null transplants (Fig. 1 B,
middle panel). To further evaluate the differences between
Stat5- and PrlR-null alveoli-like structures, we analyzed se-
rial sections. Whereas PrlR-null tissue exhibited consistently
open lumina, they were not apparent in Stat5-null tissue
(unpublished data).
 
Proliferation of PrlR- and Stat5-null mammary epithelia
 
We investigated potential causes for the lack of functional al-
veolar development in PrlR- and Stat5-null epithelia, and ex-
amined estrogen- and progesterone-mediated proliferation
(Fig. 2). Previous studies have demonstrated that acute treat-
 
ment with estrogen and progesterone for 2 d resulted in
 
 
 
15% of the wild-type ductal epithelial cells entering the
cell cycle, as assessed by BrdU labeling (Seagroves et al.,
2000). Maximal proliferation appears to occur in the alveolar
progenitors in the ducts during the first few days of preg-
nancy. The estrogen and progesterone treatment of virgin
transplants that have filled the fat pad is designed to mimic
the effect of early pregnancy on alveolar development. In
comparison to the thoracic #3 controls from the host animal,
steroid hormone–induced proliferation of PrlR-null epithe-
lium was reduced by 
 
 
 
60%, whereas proliferation of Stat5-
null epithelium was reduced by only 30% (Fig. 2 B). Thus,
whereas in both cases there was a significant reduction in
proliferation relative to the wild-type control, PrlR-null epi-
thelium exhibited a twofold greater decrease than Stat5-null
epithelium. These differences were statistically significant
(
 
P 
 
  
 
0.001).
 
Differentiation of PrlR- and Stat5-null mammary epithelia
 
There were no morphological and histological signs of milk
secretion in PrlR- and Stat5-null epithelia (Fig. 1 B). To
determine the differentiation status of PrlR- and Stat5-null
epithelia, we examined the expression of milk protein genes
(
 
 
 
-casein, whey acidic protein [WAP], and WDNM1).
Steady-state levels of these mRNAs increased in wild-type
(Fig. 3) and Stat5b-null (unpublished data) mammary
tissue during pregnancy. Expression of WAP, but not
 
 
 
-casein, mRNA was decreased in Stat5a-null mice (Fig. 3)
Figure 2. Progesterone- and estrogen-induced 
proliferation is more severely impaired in PrlR-
null than in Stat5a/b–null mammary epithelium. 
9 wk after transplantation, mice were given an 
acute, 2-d E P treatment. Mammary glands were 
removed and proliferation was evaluated by BrdU 
immunostaining. (A) Green staining represents 
BrdU-positive cells and DAPI-stained nuclei are 
blue. Merging the images shows the proliferation 
occurring mainly in the ductal epithelium. The 
number of BrdU-positive cells was clearly 
decreased in both PrlR- and Stat5-null transplants, 
as compared with the control #3 gland. (B) 
Quantitation of BrdU-positive ductal cells (mean 
percentage   SEM) is shown in the bar graph. The 
P values comparing PrlR- or Stat5-null to control (*) 
and Stat5-null to PrlR-null (**) were  0.001 as 
determined by Mann-Whitney paired t test. 
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as shown previously (Liu et al., 1997). 
 
 
 
-casein and WAP
mRNAs were not detected in PrlR- and Stat5-null epithelia
by total RNA Northern blot. On the other hand, WDNM1
mRNA was detected at lower levels in the PrlR- and Stat5-
null epithelia. Using more sensitive assays, low levels of
WAP and 
 
 
 
-casein were detected in Stat5-null epithelia
(unpublished data). These results suggest that PrlR- and
Stat5-null epithelia failed to undergo functional differentia-
tion.
 
Stat5-null epithelium have impaired cell–cell contacts 
and lack connexin 32
 
We evaluated the ultrastructure of wild-type, Stat5-, and
PrlR-null mammary epithelia at parturition by electron mi-
croscopy (Fig. 4). Mammary tissue from lactating control
mice contained secretory epithelia with features indicative of
a fully differentiated phenotype: the alveolar lumina were ex-
panded and contained casein micelles and lipid droplets
(Fig. 4, A and D). Alveolar cells contained a well-developed
Golgi apparatus and a rough endoplasmic reticulum (Fig. 4
D). In contrast, PrlR- (Fig. 4, B and E) and Stat5-null (Fig.
4, C and F) epithelial structures were highly disorganized.
Most of the alveoli-like structures in Stat5-null epithelium
had no lumina (Fig. 4, C and F). Occasionally, the lumina
that were present that were small, and did not contain casein
micelles and lipid droplets (Fig. 4 F). Often, there were sev-
eral layers of epithelia so that the lumina seemed congested
with cells (Fig. 4 C). We frequently observed several pseudo-
lumina within one structure, suggesting the inability to form
a single lumen surrounded by a single layer of epithelial cells
(unpublished data). Interestingly, the cells near the base-
ment membrane, thought to be myoepithelia, contained
lipid droplets reminiscent of secretory cells (Fig. 4 C). In
contrast, PrlR-null epithelia were more organized and the al-
veoli-like structures contained small but open lumina (Fig.
4, B and E). Neither the rough endoplasmic reticulum nor
Figure 3. Milk protein expression is impaired in Stat5- and PrlR-
null mammary epithelia. Northern blot analysis of milk protein 
mRNAs ( -casein, WAP, WDNM1) and keratin 18 (K18) mRNA in 
mammary tissue of wild-type mice (WT) and Stat5a-, 5a/b-, and 
PrlR-null epithelial transplants. V, virgin (5 wk); P13, pregnancy day 
13; Part, after parturition.
Figure 4. Disorganized structures of 
Stat5- and PrlR-null epithelia. Stat5- and 
PrlR-null mammary epithelia at parturition 
were analyzed by electron microscopy. (A 
and D) Control mammary epithelium at 
lactation day 1 was fully differentiated and 
contained secreted milk proteins and lipid 
droplets. Golgi apparatus (white long 
arrow) and RER (white long arrow) were 
detected. Lu, lumen; L, lipid droplet; N, 
nucleus; black short arrow,  -casein 
micelles; black circle, tight junction. (B 
and E) Alveoli-like structures of PrlR-null 
epithelium were more organized than 
Stat5-null epithelia. Lumina were detected 
in alveolar-like structure (white circle). The 
centrosome was located close to the 
apical membrane (black arrow). Tight 
junctions were maintained (black circle). 
(C and F) Alveoli-like structures in Stat5-
null epithelia were disorganized and cell–
cell contacts were aberrant (black arrow). 
Frequently, two or more pseudo-lumina 
were detected in one alveolar-like 
structure (black circles). The cells near the 
basement membrane contained lipid 
droplet-like structures (white arrow). Ac-
tive Golgi apparatus and a RER in Stat5- 
and PrlR-null epithelia were not apparent. 
Bars: (A–C) 2.4  m; (D–F) 1.6  m. 
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the active Golgi apparatus were prominent in PrlR- or Stat5-
null epithelial cells (Fig. 4, E and F). We observed that the
epithelial cells furthest from the basement membrane, and
therefore the most “luminal,” contained centrosomes located
close to their apical membrane as determined by the pres-
ence of microvilli (Fig. 4 E). This centrosomal orientation
suggested that these cells had recently divided and that their
cleavage plane was perpendicular to the basement membrane
potentially resulting in the epithelial layering and the crowd-
ing of the luminal space.
Epithelial cells contact each other via tight and adherens
junctions (Cereijido et al., 1998; Borrmann et al., 2000; Va-
sioukhin and Fuchs, 2001), which stabilize epithelial struc-
tures and determine their integrity. Further, these junctions
are necessary to establish and maintain cell polarity (Knust,
2000; Vicente-Manzanares and Sanchez-Madrid, 2000) that
permits vectorial secretion (Barcellos-Hoff et al., 1989). Fig.
4 D shows the morphological appearance of a tight junction
complex between the apical poles of two individual secretory
cells in wild-type epithelium. One of the most conspicuous
features of the Stat5-null epithelium was the lack of orga-
nized cell contacts. To identify possible causes for the lack of
organized cell contacts we investigated the expression of
zonula occludens (ZO)-1, a component of tight junctions.
Tight junctions were identified in PrlR- and Stat5-null epi-
thelia (Fig. 4, E and F) and visualized by ZO-1 staining (Fig.
5, A and B). We further investigated the expression of con-
nexin, a protein in the gap junction complex, in PrlR- and
Stat5-null epithelia. It has been demonstrated previously
(Pozzi et al., 1995; Locke et al., 2000) that mouse mammary
tissue expresses three connexin isoforms (Cx 43, Cx 26, and
Cx 32), which we confirmed using reverse transcription
(RT)-PCR analyses. Whereas Cx 32 mRNA was detected in
wild-type epithelia at day 1 of lactation, we were unable to
detect expression in PrlR- and Stat5-null epithelia at parturi-
tion (Fig. 5 D).
To further examine the cell adhesion defect apparent in
Stat5-null epithelial cells, we investigated the expression of
additional molecules involved in cell adhesion. Cadherins
mediate cell–cell adhesion and also contribute to the mainte-
nance of apical–basal polarity (Tepass et al., 2000). Indeed,
E-cadherin has been shown to play a role in the morphogen-
esis and growth of the mammary gland (Daniel et al., 1995;
Delmas et al., 1999). On this basis, we hypothesized that
E-cadherin expression might be altered in Stat5-null mam-
mary epithelial cells and thus contribute to the observed al-
terations in cell adhesion. However, E-cadherin expression
along cell–cell borders did not appear to be significantly per-
turbed when comparing Stat5-null and wild-type epithelia
(Figs. 5 and 7).
 
PrlR- and Stat5-null epithelia maintain virgin-like 
ductal features during pregnancy
 
Whole mount and histological analyses have demonstrated
that the formation of mammary alveolar epithelium was se-
verely impaired in the absence of the PrlR or Stat5. How-
ever, these types of analyses do not allow the identification
of the epithelial cells as ductal or alveolar. To further deter-
mine the histological identity of these cells, we investigated
the expression of proteins that characterize either ductal or
secretory alveolar epithelium. We have observed that the Na-
K-Cl cotransporter (NKCCl) is expressed at high levels in
virgin mice and is located on the basolateral membrane of
ductal epithelial cells, and unpublished data). Further,
NKCC1 expression levels decreased in developing alveoli
but are maintained in some cells of the ductal epithelia dur-
ing pregnancy. Therefore, we examined the expression of
NKCC1 by immunohistochemistry in transplanted PrlR-
and Stat5-null epithelia in virgin mice and at parturition. In
virgin mice, NKCC1 was detected in endogenous epithe-
lium and PrlR- and Stat5-null transplants (Fig. 6, A, C, and
E). At parturition, the levels of NKCC1 were sharply re-
Figure 5. Maintenance of ZO-1 
expression but loss of Cx 32 expression. 
Immunohistochemical staining of ZO-1 
(green) and E-cadherin (red) at parturi-
tion (A–C). Tight junctions (green dots) 
were present in PrlR- (A) and Stat5-null 
(B) the same as in wild-type epithelium 
(C). Arrows point to alveoli-like 
structures of PrlR- and Stat5-null epithe-
lia. (D) RT-PCR analysis of Cx 32 mRNA. 
Total RNA from wild-type, Stat5-, and 
PrlR-null transplanted epithelia at 
parturition was reverse transcribed, and 
the cDNA was subjected to PCR. Cx 32 
cDNA was detected in wild-type but not 
in PrlR- or Stat5-null samples. GAPDH 
levels were similar in all samples. 
M, marker. 
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duced in wild-type secretory alveolar cells (Fig. 6 B). In con-
trast, NKCC1 expression was consistently higher in PrlR-
and Stat5-null epithelia at parturition (Fig. 6, D and F), and
the alveoli-like structures stained strongly for NKCC1. At
pregnant day 12, wild-type alveolar cells already had reduced
NKCC1 levels (Fig. 6 G). These results suggest that the cells
forming alveoli-like structures still maintain features of duc-
tal epithelia. Smooth muscle actin, which characterizes myo-
epithelial cells, was found in PrlR- and Stat5-null, and con-
trol epithelia from virgin mice (Fig. 6, A, C, and E). At
parturition, smooth muscle actin staining demonstrated a
contiguous layer of thin myoepithelial cells surrounding the
fully expanded wild-type alveoli (Fig. 6 B). On the other
hand, PrlR- and Stat5-null (Fig. 6, D and F) epithelia exhib-
ited a staining pattern very similar to that seen in virgin
wild-type epithelium (Fig. 6 A). The expression pattern of
smooth muscle actin in alveoli-like structures was identical
to that observed in ducts (Fig. 6, A, E, and F).
 
In an attempt to identify potential markers of secretory
function, we searched the mouse EST database for genes
preferentially expressed in the lactating mammary library,
NMLMG. Using this approach, we discovered that a
sodium phosphate cotransporter isoform, Npt2b, was
highly expressed in the mouse mammary gland library de-
rived from lactating tissue, but not virgin tissue (un-
published data). Next, we examined the expression of
Npt2b during normal mammary gland development. RT-
PCR analyses demonstrated that Npt2b mRNA was not
present in virgin or early (day 13) pregnancy, but was evi-
dent during late (day 16) pregnancy through mid (day 5)
lactation (unpublished data). The cellular localization of
Npt2b protein was addressed by immunohistochemistry.
We detected expression of Npt2b protein in mammary
tissue from day 18 pregnant mice and at day one of lacta-
tion (Fig. 7), but not in virgin or early pregnant mice (un-
published data). Interestingly, Npt2b protein was ex-
Figure 6. NKCC1 and smooth muscle 
actin are expressed in PrlR- and Stat5-
null alveoli-like structures at parturi-
tion, but not in wild-type mice. 
Immunohistochemical staining of 
NKCC1 (red) and smooth muscle actin 
(green) in mammary epithelia of virgin 
mice (A, C, and E) and after parturition 
(B, D, and F). NKCC1 levels were high in 
ductal epithelium of wild-type virgin 
mice (A) and sharply reduced in alveoli 
by pregnancy day 12 (G, circle) and at 
parturition (B). PrlR- and Stat5-null 
epithelia maintained high levels of 
NKCC1 at parturition (D and F, 
compare white arrows with white 
arrow in G). 
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pressed on the apical membrane of the mammary
secretory cells (unpublished data). Taken together, these
results suggest that Npt2b is a potential marker of secre-
tory function. As mentioned above, PrlR- and Stat5-null
epithelia fail to secrete milk proteins suggesting they were
devoid of normal secretory function. Therefore, we exam-
ined the expression of Npt2b protein in these samples
(Fig. 7). Whereas the mammary secretory cells present in
wild-type epithelia showed expression of Npt2b in the
apical membrane (Fig. 7 D), Npt2b was not detected in
PrlR- and Stat5-null epithelia (Fig. 7, E and F). In con-
trast, E-cadherin (Fig. 7) was expressed in the basolateral
membrane of all samples examined.
 
Epidermal growth factor and GH can activate Stat5 in 
PrlR-null epithelium
 
Based on histological and electron microscopy studies,
Stat5- and PrlR-null epithelia exhibited differences.
Whereas Stat5-null epithelium  was highly disorganized
and did not form open lumina, PrlR-null epithelium
formed small open lumina. The observation that Stat5-
null epithelium exhibited a more severe phenotype than
PrlR-null epithelium, suggested that Stat5 might be acti-
vated to some extent by other cytokines in the absence of
the PrlR. We have recently demonstrated by Western blot
analysis that EGF and GH can activate Stat5 in mam-
mary tissue (Gallego et al., 2001). However, their respec-
tive receptors within the epithelial compartment are not
required for functional development (Gallego et al.,
2001). We now investigated whether Stat5 could be acti-
vated in PrlR-null epithelium using immunohistochemis-
try (Fig. 8). Because Stat5a is more abundant than
Stat5b, and Stat5b is not critical for alveolar develop-
ment, we examined Stat5a activation. Stat5-null epithelia
served as a negative control. At parturition, Stat5a was lo-
calized within nuclei of wild-type alveolar and ductal
Figure 7. Npt2b expression was not 
detected in PrlR- and Stat5-null alveoli-
like structures at parturition. Immuno-
histochemical staining of Npt2b (red) 
and E-cadherin (green) in mammary 
epithelia of virgin mice (A, C, and E) and 
after parturition (B, D, and F). Npt2b was 
detected in apical membranes of secreting 
epithelia from wild-type tissue (B, white 
arrow). PrlR- and Stat5-null epithelia at 
parturition did not contain Npt2b (D and 
F). E-cadherin was detected in the 
sub-apical/basolateral membrane of all 
samples (A–F). (G) Wild-type epithelia at 
pregnancy day 12 did not express 
Npt2b. Du, duct. 
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cells, which is indicative of its active state (Fig. 8 A). In
contrast, only a few cells in PrlR-null epithelia exhibited
nuclear, and thus activated Stat5a. However, upon injec-
tion with EGF or GH, extensive nuclear translocation of
Stat5 was observed in PrlR-null epithelium (Fig. 8 B) in-
dicative of Prl-independent activation of Stat5a.
 
Discussion
 
Here we demonstrate that Stat5 controls the establish-
ment of functionally differentiated and secreting alveoli
during pregnancy (Fig. 9). This pathway is activated to a
large extent, but not exclusively, through the PrlR. We
propose that activation of the Stat5 pathway by prolactin,
GH and epidermal growth factor transduces signals that
instruct cells at the branch points to proliferate and adopt
alveolar characteristics. Further, we suggest that Stat5 de-
termines cell fate through the establishment of cell–cell
adhesion.
 
The PrlR–Stat5 pathway is obligatory for mammary 
alveolar cell fate
 
The transcription factor Stat5 is central to several signaling
pathways, and is activated by various cytokines through their
respective receptors and Jak2 (Ihle, 2001). Because Stat5-
null mice are infertile (Teglund et al., 1998), their mam-
mary development had not been studied during pregnancy.
We avoided the problem of infertility through the transplan-
tation of knockout mammary epithelia into wild-type hosts.
Although a ductal tree developed in the absence of Stat5, no
alveolar development was apparent after one pregnancy.
Whereas Stat5-null mammary epithelium exhibited a similar
 
phenotype, it was distinct from that observed in the absence
of the PrlR (Fig. 9). Ductal branching occurred in the ab-
sence of Stat5, but the alveoli-like structures did not form
lumina as were observed in the absence of the PrlR. Our re-
sults suggest that Stat5 plays a role in regulating cell organi-
zation through cell–cell contacts independent of PrlR activa-
tion. Based on molecular markers that characterize ductal
epithelia and secretory alveolar epithelia, we suggest that the
PrlR- and Stat5-null alveoli-like structures have retained
ductal-like characteristics. Thus, we propose that an early
function of the prolactin pathway in mammary epithelia is
the specification and determination of alveolar epithelia.
Two separate and distinct lineage-limited mammary epithe-
lial progenitors have been identified in the mouse mammary
gland (Kordon and Smith, 1998; Smith, 1996). The failure
to develop secretory alveoli may be either due to a failure to
generate the alveoli-limited progenitor or the inability of the
alveoli-limited progenitor and its progeny to respond to pro-
lactin signals. It is apparent that proliferation of ductal epi-
thelia can occur in the absence of a functional PrlR–Stat5
pathway. However, inactivation of the PrlR or Stat5 results
in the formation of small alveoli-like structures with ductal
features that we propose to name “ductoli.” Even after sev-
eral pregnancies, we did not detect functional alveoli in
PrlR- and Stat5-null transplants (unpublished data). This
suggests that if compensatory pathways are activated, they
are unable to elicit functional alveolar development.
In addition to the mammary gland phenotype observed in
the transplant studies described herein, the Stat5-null mice ex-
hibit phenotypes in other tissues and cell types consistent with
the inactivation of several cytokine signaling pathways (Teg-
lund et al., 1998). Loss of Stat5 disrupts IL-2 signaling and re-
sults in impaired T cell proliferation and a failure to express
Figure 8. Epidermal growth factor and GH can activate Stat5a in PrlR-null epithelium. Immunohistochemical staining of Stat5a (green) and 
E-cadherin (red) in mammary epithelium at parturition (A) and in virgin tissue after hormone injection (B). Arrows show Stat5a nuclear stain-
ing. (A) In PrlR-null epithelium, some Stat5a nuclear staining was detected. In contrast, almost all cells in wild-type epithelia had Stat5a nu-
clear translocation. (B) Virgin mice carrying PrlR- and Stat5-null epithelia were injected with EGF or GH. Extensive nuclear localization of 
Stat5a was observed in PrlR-null epithelium but not in Stat5-null epithelium. 
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genes controlling cell cycle progression (Moriggl et al., 1999).
In addition, Stat5 has also been linked to cell survival (Hum-
phreys and Hennighausen, 1999; Socolovsky et al., 1999;
Schwaller et al., 2000; Ihle, 2001). Lastly, Stat5 has been linked
to B cell differentiation induced by IL-4 and IL-7 (Sexl et al.,
2000) and Stat5a is required for functional differentiation, but
not proliferation, of mammary epithelial cells (Liu et al., 1997).
 
Cell–cell adhesion defects in PrlR- and Stat5-null 
mammary epithelia
 
The absence of Stat5 resulted in defective cell–cell adhesion
as assessed by electron microscopy. Thus, in control samples
the basolateral membranes of neighboring cells were in close
contact with each other. Conversely, there was evidence of
gaps between adjacent cells in the Stat5-null samples. This
suggests that Stat5 mediates signals that promote cell–cell
adhesion. The expression of E-cadherin and ZO-1, proteins
known to be involved in cell–cell adhesion and associated
with tight junctions, respectively (Gumbiner, 1996), re-
vealed normal staining patterns in both the PrlR- and Stat5-
null samples. However, it is possible that whereas adjacent
cells express detectable E-cadherin, they may not physically
contact each other. In addition to E-cadherin, the process of
cell adhesion involves additional proteins and it cannot be
ruled out that any one of these are responsible for the cell
adhesion defects that we observed.
 
The establishment of cell–cell adhesion is not only impor-
tant for epithelial organization, but also for effective com-
munication between individual cells. Such intercellular
communication allows neighboring cells within a defined
structural unit to respond in unison to a given signal. For ex-
ample, the gap junction subunit Cx 43 is expressed in the
myoepithelial cell compartment, and it has been suggested
that this may help coordinate myoepithelial contraction and
milk ejection upon oxytocin stimulation (Plum et al., 2000).
The lack of appropriate gap junction protein expression, and
by extension intercellular communication, could disrupt the
cellular unit (i.e., alveoli) whose formation may be required
for their full functional development. It has previously been
shown that the mouse mammary gland expresses three con-
nexin isoforms, Cx 26, Cx 32, and Cx 43 (Pozzi et al.,
1995). Whereas Cx 43 is expressed in myoepithelial cells,
both Cx 26 and Cx 32 are expressed in the epithelial com-
partment. Interestingly, Cx 32 expression is induced at lac-
tation and cannot readily be detected at other time points,
suggesting that it may contribute to the attainment of a
secretory phenotype (Locke et al., 2000). Furthermore, Cx
32 has been shown to interact with proteins in the tight
junction complex and determine cell polarization in hepato-
cytes (Kojima et al., 2001). Although we were able to detect
Cx 32 expression in control samples at parturition, neither
PrlR- nor Stat5-null epithelia expressed detectable levels of
Cx 32. It is possible that the lack of Cx 32 expression in
PrlR- and Stat5-null epithelia is the result of a lack of secre-
tory differentiation. Alternatively, it is possible that Cx 32 is
a Stat5 target gene. In fact, the mouse Cx 32 gene promoter
contains an interferon 
 
 
 
–activated sequence site at position
–800, suggesting that this promoter may be under direct
prolactin control.
We have provided experimental evidence on the level of
histology and electron microscopy that cell-cell adhesion
and organization is impaired in the absence of Stat5, and to
a lesser extent in the absence of the PrlR. Although we have
shown apparent normal localization of E-cadherin and ZO-1,
this cannot be a true measure for their functional integrity,
which needs to be addressed in future studies. There is now
widespread interest in the regulation of mammary epithelial
cells by cell–cell adhesion molecules. It is likely that many
proteins, including the transcription factor Stat5, control
these processes.
 
Pathway redundancy
 
There were notable differences when comparing the individ-
ual phenotypes on the histological level. In particular, epi-
thelial development in the absence of the PrlR was more in-
hibited than in the absence of Stat5. This could in part be
explained by a reduction in the proliferative capacity of
PrlR-null epithelium relative to Stat5-null epithelium. Such
differences may be due to the activation of compensatory
signaling pathways. For example, mitogen-activated protein
kinase and PI3K can be activated upon Prl stimulation. It is
also possible that other Stats (i.e., Stat1 and/or Stat3) may
be recruited to Jak2 in the absence of Stat5, thus resulting in
additional stimulation of epithelial development.
There was evidence of open lumina in the PrlR-, but not
in the Stat5-null, transplants. Furthermore, the ductoli
Figure 9. PrlR and Stat5 control the cell fate of mammary 
alveolar epithelium. Wild-type mammary epithelium differentiates 
into functional alveoli during pregnancy. However, PrlR- and Stat5-
null epithelia do not undergo alveolar development. The null 
epithelia maintain ductal features and cell proliferation at the 
branching points results in the development of “ductoli” (ductal
feature but alveoli-like structure). In contrast to Stat5-null ductoli, 
PrlR-null ductoli contain open lumina. In the absence of Stat5 
ductolar cells have impaired cell–cell contacts. The ductoli do not 
differentiate into functional alveoli. Blue line, ductal development; 
red line, alveolar development. The myoepithelial cells surrounding 
the alveoli are flat. The outer cell layer of ductoli is positive for 
smooth muscle actin and can thus be considered to be of 
myoepithelial nature. 
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present in the PrlR-null epithelia were more organized
compared with Stat5-null epithelia, suggesting that Stat5 is
necessary for appropriate organization of individual cells
into cohesive cellular structures. Whereas Prl is probably
the key cytokine responsible for the activation of Stat5, we
demonstrated that Stat5 has some residual activity in the
absence of the PrlR. Because both GH and EGF activate
Stat5 in the absence of the PrlR, it is likely that these two
cytokines contribute to the formation of cell–cell contacts
and thus a lumen.
 
Pathways controlling alveolar epithelial development
 
We have established that the PrlR and Stat5 are each essential
for the attainment of functional alveologenesis. Several other
genes and signaling pathways that control alveolar develop-
ment have been identified, including ErbB2 (Jones and Stern,
1999) and ErbB4 (Jones et al., 1999), cyclin D1 (Fantl et al.,
1995; Sicinski et al., 1995), C/EBP
 
 
 
 (Robinson et al., 1998;
Seagroves et al., 1998), the osteoclast differentiation factor
RANKL and its receptor RANK (Fata et al., 2000), and the
helix-loop-helix protein Id2 (Mori et al., 2000). Data from
these mouse models suggests that alveologenesis is a complex
process requiring the functional cooperation of numerous mol-
ecules. Interestingly, comparable phenotypes were observed in
some of these mice, i.e., lack of alveolar development. Develop-
mental roles for ErbB2 and 4 have been suggested based on
transgenic mice that express dominant negative forms under
control of a mouse mamary tumor virus long terminal repeat.
Expression of a dominant negative ErbB2 resulted in con-
densed alveoli and reduced luminal secretion at parturition
(Jones and Stern, 1999). ErbB4-dominant negative epithelium
formed condensed alveoli and failed to expand at mid lacta-
tion, which correlated with reduce expression of 
 
 
 
-lactalbumin
and WAP and a loss of Stat5 activity (Jones et al., 1999).
Similar to the models described here, C/EBP
 
 
 
-null mice
possess undifferentiated alveolar epithelium; in contrast,
branching morphogenesis was also impaired. C/EBP
 
 
 
 mRNA
levels in PrlR- and Stat5-null transplanted epithelia at partu-
rition were similar to those seen in wild-type tissue (unpub-
lished). These results suggest that C/EBP
 
 
 
 expression is es-
sentially independent of the PrlR–Stat5 pathway, although
they may converge at the 
 
 
 
-casein promoter (Wyszomierski
and Rosen, 2001). In the absence of RANKL, a growth fac-
tor produced by mammary epithelia in the second half of
pregnancy, mammary epithelia also fail to develop (Fata et
al., 2000). Because Prl can activate RANKL expression (Fata
et al., 2000), it may be downstream of Stat5. However, both
RANKL and RANK are expressed at high levels in PrlR- and
Stat5-null transplanted epithelia at parturition (unpublished
data), suggesting that these pathways are parallel and not de-
pendent on each other. Id2-deficient mice also show severely
impaired mammary gland development (Mori et al., 2000).
Furthermore, Id2-deficient mammary epithelia exhibit re-
duced phosphorylation of Stat5. Normal levels of Id2
mRNA were detected in PrlR- and Stat5-null epithelia at
parturition (unpublished data), suggesting that Id-2 is not
downstream of Stat5. The presence of several, and appar-
ently parallel, pathways controlling mammary alveolar de-
velopment further emphasizes that distinct signals contrib-
ute to alveologenesis. At this point it is not clear whether
 
these pathways have unique molecular targets leading to the
formation of functional alveoli. The understanding of sig-
naling pathways that are required for the formation of mam-
mary epithelia but are dispensable for life of the organism it-
self provides a unique opportunity to develop molecular
interventions and prevention for breast cancer.
 
Materials and methods
 
Animals
 
The Stat5a/b–null mice (Teglund et al., 1998) were bred into the C57BL/6
background. PrlR-null mice (Ormandy et al., 1997b) were in a C57BL/6
background, and Stat5a-null mice (Liu et al., 1997) were in a C57BL/6 and
129 mixed background. For the transplantation studies of PrlR- and Stat5-
null mammary epithelia, athymic NCr-nu/nu mice were used as hosts.
Wild-type littermates were used as controls. More than 30 PrlR- and Stat5-
null transplants each were analyzed. For hormone injection studies, the
transplanted virgin mice (12 wk after transplantation) were used. The mice
were injected by intraperitoneally with either murine GH (5 
 
 
 
g/g of body
weight), or human EGF (10 
 
 
 
g/g of body weight). Mammary glands were
harvested 15 min later, fixed in 4% paraformaldehyde for 4 h, and pro-
cessed for paraffin embedding and sectioning by standard procedures.
 
Antibodies
 
Polyclonal anti–rabbit Stat5a antibodies have been described previously
(Liu et al., 1996). Mouse monoclonal E-cadherin and smooth muscle actin
antibodies were obtained from Transduction Laboratories, polyclonal anti–
rabbit ZO-1 antibodies were purchased from Zymed Laboratories, and
polyclonal anti–rabbit NKCC1 antibodies (Moore-Hoon and Turner, 1998)
were a gift from Dr. Jim Turner (National Institute of Dental and Craniofa-
cial Research, National Institutes of Health, Bethesda, MD). The poly-
clonal anti–rabbit Npt2b antibodies (Hilfiker et al., 1998) were a gift from
Dr. Jurg Biber (Department of Physiology, University of Zurich, Zurich,
Switzerland).
 
Transplantation of adult mammary epithelia into the cleared fat 
pad of nude mice
 
The transplantation was performed as previously described (DeOme et al.,
1959). In brief, small pieces of mammary tissue were excised from mature
virgin female wild-type, Stat5-, or PrlR-null mice. Athymic nude mice
(3-wk-old) were anesthetized with an intraperitoneally injection of avertin
and the proximal part of the inguinal gland containing the mammary epi-
thelium was excised. Pieces of mammary tissue from a PrlR- and a Stat5-
null mouse were grafted into contralateral cleared fat pads of recipients.
The other combinations of transplants were Stat5:wild type and PrlR:wild
type. To assess the completeness of clearing, the excised endogenous
glands were processed for whole mount staining according to standard
protocols. 8 wk after transplantation, fat pads containing transplants were
harvested from virgin hosts. Alternatively, the hosts were bred and tissue
was harvested on the day of parturition. For whole mounts, mammary
glands were removed, fixed in Carnoy’s fixative overnight and stained in
carmine alum.
 
Immunofluorescence
 
After fixation in Tellyesniczky’s fixative for 4 h at room temperature, tis-
sues were embedded in paraffin and sectioned at 5 
 
 
 
m. Sections were
cleared in xylene and rehydrated. Antigen retrieval was performed by heat
treatment using an antigen unmasking solution (Vector Laboratories) and
tissue sections were blocked for 30 min in PBST containing 10% goat or
horse serum. For ZO-1 detection, antigen retrieval was performed by pro-
tease treatment (Auto/Zyme Reagent set; Biomeda Corp.) at 37
 
 
 
C for 10
min. Sections were incubated with E-cadherin (1:1,000) and ZO-1 (1:500)
antibodies, E-cadherin (1:1,000) and Npt2b (1:100) antibodies, smooth
muscle actin (1:1,000) and NKCC1 (1:1,000) antibodies or E-cadherin
(1:1,000), and Stat5a (1:250) antibodies. The primary antibodies were al-
lowed to bind for 60 min at 37
 
 
 
C except for Stat5a:E-cadherin and ZO-1:
E-cadherin (4
 
 
 
C, overnight). Nonspecifically bound antibody was removed
by rinsing in PBST before the addition of both anti–mouse FITC-conjugated
(1:250) and anti–rabbit Texas red–conjugated (1:250) secondary antibod-
ies. Sections were incubated in the dark for 30 min, washed in two
changes of PBST, and mounted in Vectashield (Vector Laboratories, Inc.).
Fluorescence was visualized with a Zeiss Axioscop microscope equipped
with FITC, TRITC, and FITC:TRITC filters. Images were captured using a
Sony DKC5000 digital camera. 
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Analysis of cellular proliferation
 
After 9 wk, the transplant recipients were treated for 48 h with 1 
 
 
 
g 
 
 
 
-estra-
diol (E) (Sigma-Aldrich) and 1 mg progesterone (P) (Sigma-Aldrich) in
100 
 
 
 
l sesame oil via a single interscapular subcutaneous injection behind
the neck. After acute hormone treatment, both of the transplanted number
4 inguinal mammary glands and an endogenous number 3 gland (control)
were removed. 2 h before sacrifice, mice were injected with 0.3 mg BrdU
per 10 g body weight (Amersham Pharmacia Biotech). Tissue was fixed in
4% paraformaldehyde in PBS for 2 h at 4
 
 
 
C. Immunofluorescence and
BrdU-positive cell counting were performed as previously described (Sea-
groves et al., 2000). In brief, paraffin sections (5–7 
 
 
 
m) were dewaxed and
subjected to microwave antigen retrieval in 10 mM citrate buffer, pH 6.0.
After blocking in 5% BSA/0.5% Tween 20 for 4 h at room temperature,
sections were incubated with anti–BrdU-FITC–conjugated antibody (1:5;
Becton Dickinson) in blocking solution overnight at room temperature. Af-
ter PBS washes, slides were mounted in Vectashield 
 
 
 
 DAPI medium
(Vector Laboratories). At least four glands per genotype were used for each
experiment (endogenous control #3, 
 
n 
 
  
 
5; PrlR-null epithelia trans-
planted gland, 
 
n 
 
 
 
 5; Stat5-null epithelia transplanted gland, 
 
n 
 
  
 
4). Cells
from 16 fields at 60
 
 
 
 magnification were counted from each sample. The
number of BrdU-positive cells in a given field was expressed as a percent-
age of the total number of DAPI-stained cells. Statistical significance was
determined by Mann-Whitney paired 
 
t
 
 test.
 
Gene expression analysis
 
Total RNA was isolated from fresh or frozen tissues and Northern blots
were performed as described previously (Robinson et al., 1995). In brief,
10 
 
 
 
g of total RNA was loaded in each lane. Membranes were hybridized
with random-primed [
 
 
 
-
 
32
 
P] dCTP-labeled probes in QuickHyb solution
for 3 h at 65
 
 
 
C. Washes were performed in 0.1 
 
  
 
SSC/0.1% SDS at 65 C.
At first, the membrane was hybridized with WAP and  -casein probes to-
gether and exposed to x-ray films. After stripping, membranes were rehy-
bridized with WDNM1 and keratin 18 probes together. A 415-bp WAP-
specific probe was generated by RT-PCR with primers 5 -GTA-CCA-TGC-
GTT-GCC-TCA-TC-3  and 5 -GCT-GCT-CAC-TGA-AGG-GTT-ATC-3 . A
577-bp  -casein–-specific probe was generated by RT-PCR with primers
5 -CTA-AAG-TTC-ACT-CCA-GCA-TCC-3  and 5 -CAT-TTC-CAG-TTT-
CAG-TCA-GTT-C-3 . A full-length cDNA for WDNM1 was used (Robin-
son et al., 1995). The keratin 18–specific probe was a 1.1-kb EcoRI cDNA
fragment (Singer et al., 1986).
Electron microscopy
Small pieces of mammary tissue were cut, minced into 1-mm cubes,
and fixed in a 0.025% solution of glutaraldehyde and 3.8% paraformal-
dehyde in PBS, pH 7.2, for 2 h. The tissue was rinsed in PBS and post-
fixed in 2% osmium tetroxide in 0.5 M sodium cacodylate buffer for
2 h, and dehydrated in a graded series of acetone solutions (Blanchette-
Mackie and Scow, 1971). Temperature was maintained at 4 C from ex-
cision through dehydration and tissues were embedded in epon at
room temperature (Luft, 1961). Sections were cut on a Reichert Om U2
ultramicrotome. Thick sections were stained with Toluidine blue in 1%
sodium borate (pH 8.3) (Trump et al., 1961). Thin sections were stained
with Karnovsky’s lead hydroxide (Karnovsky, 1961) and uranyl acetate
(Zobel and Beer, 1961) and examined with a JEOL 1010 electron mi-
croscope.
RT-PCR assays
Total RNA (1  g) was transcribed into cDNA using Thermoscript reverse
transcriptase (Life Technologies, Inc.) according to the manufacturer’s
protocol. Total RNA (1  g) was first incubated with dNTPs and an oligo-
dT(12–18) primer at 65 C for 5 min. All components were added except the
reverse transcriptase, and the reaction was incubated at 42 C for 2 min.
Thermoscript RT (50 units) was added to each reaction and incubated for
a further 50 min. For controls, the samples without RT reactions were am-
plified. Single-stranded RNA was degraded by treating the reaction with
Escherichia coli RNase H for 20 min at 37 C. PCR assays were performed
for Cx 32 and GAPDH cDNA. Cx 32 gene-specific primers were 5 -GTT-
GCA-ACC-AGG-TGT-GGC-AGT-G-3  and 5 -CGG-AGG-CTG-CGA-
GCA-TAA-AGA-C-3 . GAPDH gene-specific primers were 5 -CAA-CGG-
GAA-GGG-CCC-CCA-TAC-CAT-C-3  and 5 -ACG-ACG-GAC-ACA-TTG-
GGG-GTA-G-3 . The template was first denatured at 94 C for 2 min fol-
lowed by 35 cycles (Cx 32) or 25 cycles (GAPDH) of denaturation (94 C,
40 s), annealing (65 C, 40 s), and extention (72 C, 1 min). A final extention
at 72 C for 10 min was performed.
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